Log In
Print this Print this

PNAG Vaccine (AV0328)

  Manage Alerts
Collapse Summary General Information
Company Alopexx Vaccine LLC
DescriptionVaccine based on deacetylated poly-N-acetyl glucosamine (PNAG)
Molecular Target Poly-N-acetyl glucosamine (PNAG)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsPrevent bacterial infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today